Beyond distance and heart rate: Reading 6-minute walk test via blood pressure variability in chronic heart failure

Abstract

The six-minute walk test (6MWT) remains a tool for assessing exercise capacity in heart failure, with six-minute walk distance as the endpoint. To enhance interpretability, vital signs such as heart rate and blood pressure may also be recorded in accordance with technical statements. However, beta-blockers often blunt heart-rate-based readouts during the 6MWT, thereby reducing the interpretability of six-minute walk distance. Akimova et al recently published a study in World Journal of Experimental Medicine, which identified blood pressure variability (BPV) as a minutes-scale recovery signal during a paired 6MWT. The index targets the 20-minute post-exercise recovery window and uses point-to-point systolic blood pressure change to help characterize cardiac reserve and to enhance interpretation of the 6MWT. The measure is low cost and easy to implement, and BPV remains associated with imaging indices such as left ventricular ejection fraction in beta-blocked heart failure populations. Importantly, this should be viewed as an early, proof-of-concept insight. Future work should confirm these findings in multicenter prospective studies, define operational protocols and thresholds for BPV, and explore relationships with clinical outcomes, thereby further enhancing the value of minutes-scale BPV.

Keywords: Six-minute walk test; Heart failure; Blood pressure variability; Beta-blockers; Cardiac function

Core Tip: The six-minute walk test (6MWT) is a tool for the assessment of exercise capacity in chronic heart failure. During beta-blocker therapy, heart-rate readouts during 6MWT are often blunted. Blood pressure variability measured in the recovery window following 6MWT may overcome this limitation, offering a low-cost method to assess compensatory reserve and enhance cardiac interpretation.